Athens Pharmaceutical Producer 

40 registered pharma & cosmetic licenses

€ 14,000,000

Our client is a pharmaceutical and cosmetics manufacturer and distributor based in Athens, Greece that is interested in selling their assets and/or business as a going concern. Their asking price is € 14 million for 100% of equity. The current management team is willing to stay on to support the transition. 

​

The company assets include a 30,000 sq. meter plot in the north-eastern suburbs of Athens, along a major highway and in close proximity to the Athens Ring Road, Airport and Lavrio Port. There is a building of 7,000 sq. meters, and an additional 20,000 sq. meters can be built on the plot.

 

All operating and product licenses are in place. All debt is currently being serviced. The company is being sold free of any debt and obligations if sold as a going concern. 

​

The current product line up includes own products and imported brands sold OTC and by prescription (Rx). The pharma product range includes pills, sprays, and lotions for:

 

• alimentary tract & metabolism

• antithrombotic agents

• cardiovascular drugs

• antimycotics

• antibacterials

• anti-inflammatory and antirheumatic products

• bone disease drungs

• drugs for muscular skeletal disorders

• antidepressants

• psychoanaleptics

 

The cosmetics product range that is and can be produced is wide, and includes the following in addition to pharma pills/tabs:

 

• Shampoo

• Foam Bath & Shower

• Liquid & Solid Soaps

• Body Creams

• Hair Lotions

• Hair Masks

• Hair Gels

• Shaving & Aftershave Products

• Hand & Nail Creams

• Face Creams

• Emulsions & Face Clarifying Lotions

• Mouthwash Products

• Toothpastes

• Essential Oils

 

In addition to own production, the company imports a range of cosmetics from European producers.

 

This company could comprise an option for expanding into the European Union cosmetics and pharmaceuticals production and distribution market.  

​

​

Disclaimer: 

Navigator Consulting & Innovation Partners Ltd. has been mandated by the asset owners to explore a sale of the assets and/or enterprises mentioned in this post. This information is posted here for public information purposes only and does not constitute a solicitation or recommendation to purchase this asset. All information provided is accurate and has been provided by the asset owners to Navigator. Investor due diligence is strongly recommended. Further information can be provided to qualified investors and mandated investor representatives upon request.